ICU Medical Inc (ICUI)

Price$136.61

Value ScoreC

Growth ScoreD

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-15.89%

Price vs S&P 500 (4W)8.06%

VGM Score42.80

Market Capitalization$3.41B

P/E Ratio (Annual)4664.44x

All Metrics

P/CF (Annual)18.98x

Book Value / Share (Quarterly)$84.50

P/TBV (Annual)2.36x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-0.72%

Cash Flow / Share (Quarterly)$2.96

Price vs S&P 500 (YTD)-12.41%

Gross Margin (TTM)37.93%

Net Profit Margin (TTM)2.15%

EPS (TTM)$1.85

10-Day Avg Trading Volume0.32M

EPS Excl Extra (TTM)$1.85

Revenue Growth (5Y)11.91%

EPS (Annual)$0.03

ROI (Annual)0.02%

Gross Margin (Annual)36.84%

Net Profit Margin (5Y Avg)-0.33%

Cash / Share (Quarterly)$11.54

P/E Basic Excl Extra (TTM)73.68x

Revenue Growth QoQ (YoY)-12.32%

EPS Growth (5Y)-62.61%

P/E Normalized (Annual)4664.44x

ROA (Last FY)0.02%

Revenue Growth TTM (YoY)-10.88%

EBITD / Share (TTM)$3.66

ROE (5Y Avg)-0.91%

Operating Margin (TTM)4.09%

Cash Flow / Share (Annual)$3.36

P/B Ratio1.62x

P/B Ratio (Quarterly)1.53x

Net Income / Employee (Annual)$100

EV / Revenue (TTM)2.05x

Net Interest Coverage (TTM)1.05x

ROA (TTM)1.14%

EV / EBITDA (TTM)48.59x

EPS Incl Extra (Annual)$0.03

Current Ratio (Annual)2.39x

Quick Ratio (Quarterly)1.08x

3-Month Avg Trading Volume0.29M

52-Week Price Return2.78%

EV / Free Cash Flow (Annual)53.28x

P/E Incl Extra (TTM)73.68x

Revenue / Employee (TTM)$165,900

Tangible BV / Share (Quarterly)$60.54

P/S Ratio (Annual)1.53x

Asset Turnover (Annual)0.55x

52-Week High$160.29

Operating Margin (5Y Avg)2.84%

EPS Excl Extra (Annual)$0.03

CapEx CAGR (5Y)-0.68%

Tangible BV CAGR (5Y)2.69%

26-Week Price Return-7.97%

Quick Ratio (Annual)1.05x

13-Week Price Return-0.10%

Total Debt / Equity (Annual)0.61x

Current Ratio (Quarterly)2.34x

Enterprise Value$4.41B

Revenue / Share Growth (5Y)8.77%

Asset Turnover (TTM)0.53x

Book Value / Share Growth (5Y)3.86%

Revenue / Employee (Annual)$171,600

Inventory Turnover (Annual)2.35x

Pretax Margin (Annual)0.20%

Cash / Share (Annual)$12.47

3-Month Return Std Dev36.12%

Gross Margin (5Y Avg)34.43%

Net Income / Employee (TTM)$3,600

EBITDA CAGR (5Y)-1.91%

EBITDA Interim CAGR (5Y)-11.76%

ROE (Last FY)0.03%

Net Interest Coverage (Annual)1.16x

EPS Basic Excl Extra (Annual)$0.03

P/FCF (TTM)40.24x

Receivables Turnover (TTM)11.60x

EV / Free Cash Flow (TTM)59.59x

Total Debt / Equity (Quarterly)0.61x

EPS Incl Extra (TTM)$1.85

Receivables Turnover (Annual)12.28x

ROI (TTM)1.35%

P/S Ratio (TTM)1.58x

Pretax Margin (5Y Avg)-0.34%

Revenue / Share (Annual)$89.59

Tangible BV / Share (Annual)$60.36

Forward P/E15.68x

Free OCF CAGR (5Y)-7.51%

Price vs S&P 500 (52W)-21.59%

P/E Ratio (TTM)73.68x

Year-to-Date Return-4.25%

5-Day Price Return3.78%

EPS Normalized (Annual)$0.03

ROA (5Y Avg)0.07%

Net Profit Margin (Annual)0.03%

Month-to-Date Return0.90%

Cash Flow / Share (TTM)$8.35

EBITD / Share (Annual)$3.60

Operating Margin (Annual)3.93%

LT Debt / Equity (Annual)0.60x

P/CF (TTM)20.39x

ROI (5Y Avg)0.06%

P/E Excl Extra (TTM)73.68x

LT Debt / Equity (Quarterly)0.60x

EPS Basic Excl Extra (TTM)$1.85

P/TBV (Quarterly)2.13x

P/B Ratio (Annual)1.66x

Inventory Turnover (TTM)2.24x

Pretax Margin (TTM)0.52%

Book Value / Share (Annual)$86.03

Price vs S&P 500 (13W)-8.35%

Net Margin Growth (5Y)-66.24%

Beta0.77x

P/FCF (Annual)41.22x

Revenue / Share (TTM)$85.65

ROE (TTM)2.19%

52-Week Low$107.00

vGradeC

gGradeD

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 261.97est. 1.79

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.17

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
ICUIICU Medical Inc	C	D	C	$136.61
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53

About

ICU Medical is a pure-play infusion therapy company providing consumables, systems, and services across the full IV care continuum. The company has built top-tier market positions through strategic acquisitions, including Hospira Infusion Systems (2017) and Smiths Medical (2022), with revenues split across consumables (50%), infusion systems (30%), and vital care (20%). Over 60% of sales are generated in the United States.